AbCellera Biologics's total assets for Q3 2025 were $1.36B, a decrease of -3.29% from the previous quarter. ABCL total liabilities were $391.95M for the fiscal quarter, a -0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.